“…In addition to G13513A, at least 10 other MTND5 mutations have been reported to be associated with the oxidative phosphorylation disease. 20,26 In this study, we reported a new MTND5 point mutation, T13046C (p.M237T), which was also detected in a patient with typical MELAS/LS overlap syndrome (patient 1). Although functional studies of the new sequence variant have to be performed, we consider the T13046C to be the causative mutation in the patient 1 based on its heteroplasmy, strong conservation and absence in several tissues of the unaffected mother of the index patient.…”